Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.clim.2015.04.021 http://scihub22266oqcxt.onion/10.1016/j.clim.2015.04.021 C4628556!4628556!25979820     free     free     free       Clin+Immunol 2015 ; 161 (1): 23-30 Nephropedia Template TP {{tp|p=25979820|t=2015. Proteomics and Autoimmune Kidney Disease |pdf=|usr=}}{{25979820}} gab.com Text Proteomics and Autoimmune Kidney Disease JO: Clin Immunol http://www.kidney.de/pget.php?&tw=1&pmid=25979820 #FOAvip Proteomics has long been considered an ideal platform, and urine an ideal source for biomarker discovery in human autoimmune kidney diseases. A number of studies have examined the urine proteome to identify biomarkers of disease activity, kidney pathology, and response to therapy. Increasingly, proteomic studies of kidney disease have expanded to include blood, circulating cells and kidney tissue. Recently the clinical potential of renal proteomics has been realized through a handful of investigations whose results appear to be applicable to patient care. In this review, approaches to the proteomic evaluation of autoimmune kidney diseases will be considered in the context of developing clinically useful disease biomarkers. Twit Text FOAVip Proteomics and Autoimmune Kidney Disease ????Clin Immunol http://www.kidney.de/pget.php?&tw=1&pmid=25979820 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25979820 #FOAvip English Wikipedia <ref>{{Cite pmid|25979820}}</ref> Proteomics and Autoimmune Kidney Disease #MMPMID25979820 Rovin BH; Klein JB Clin Immunol 2015[Nov]; 161 (1): 23-30 PMID25979820show ga Proteomics has long been considered an ideal platform, and urine an ideal source for biomarker discovery in human autoimmune kidney diseases. A number of studies have examined the urine proteome to identify biomarkers of disease activity, kidney pathology, and response to therapy. Increasingly, proteomic studies of kidney disease have expanded to include blood, circulating cells and kidney tissue. Recently the clinical potential of renal proteomics has been realized through a handful of investigations whose results appear to be applicable to patient care. In this review, approaches to the proteomic evaluation of autoimmune kidney diseases will be considered in the context of developing clinically useful disease biomarkers. äProteomics and Autoimmune Kidney Disease (epmc).pdf DeepDyve Pubget Overpricing